Insulin Syringes (10 Pack)

Sale!

( 420 Reviews )

Pack of 10 sterile 1ml insulin syringes with 29G needles. Perfect for precise peptide research dosing. Each syringe is individually wrapped and ready for use.

Dosage

1ML

Bundles

You'll also need Bacteriostatic Water

Required to reconstitute lyophilized peptides before use in research.

Free shipping

on orders over £100

60-day money-back

guarantee

Secure checkout

256-bit SSL

1ml

CAPACITY

Per syringe

29G

NEEDLE GAUGE

Ultra-fine

10

QUANTITY

Per pack

100%

STERILE

Individually wrapped

Insulin Syringe: Complete Guide to Usage, Safety, and Clinical Research

Discover everything about insulin syringes — how they work, clinical research findings, safety profiles, compound information, and expert FAQs. Trusted, medically accurate content for patients and healthcare professionals.

Key findings from published peer-reviewed research studies.

Pain Reduction

35%

Less injection pain with 31G needles.

Dosing Accuracy

Insulin waste saved per injection.

Lipohypertrophy

20–40% of insulin-injecting patients develop lipohypertrophy due to poor injection site rotation technique.

Pediatric Safety

14 RCTs

Confirming 4 mm needle safety in children

1. Needle Gauge and Patient Comfort

A landmark study published in Diabetes Technology & Therapeutics found that 31G, 4 mm needles significantly reduced injection pain compared to 29G

2. Injection Depth and Insulin Absorption

Subcutaneous delivery using 4–6 mm needles consistently produced stable pharmacokinetic profiles.

3. Needle Reuse and Infection Risk

Injection pain (up to 35% increase)
Risk of lipohypertrophy (localized fat buildup)
Bacterial contamination risk

4. Glycemic Outcomes

A meta-analysis of 14 randomized controlled trials concluded that patients using low dead-space, fixed-needle insulin syringes achieved better HbA1c outcomes.

5. Pediatric Use

Studies in Pediatric Diabetes confirm that 4 mm, 32G needles are safe and effective for children and lean adolescents, with equivalent glucose control and substantially lower injection anxiety scores compared to longer needles.

Safety information based on available preclinical and clinical data.

Reuse Risk

1st use

Needle barb forms after a single use

Infection Control

Infection risk eliminated with proper hygiene

Site Rotation

2 cm

Minimum rotation distance per injection

Hypoglycemia

5x

Faster absorption risk from IM injection

✅ General Safety

Insulin syringes are classified as Class II medical devices by the U.S. Food and Drug Administration (FDA)

🔴 Rare but Serious Risks

Hypoglycemia from dosing errors or intramuscular delivery
Lipodystrophy with long-term poor rotation
Needle stick injury to caregivers (use safety-engineered syringes where available)
Insulin degradation if needle is contaminated before multi-dose vial use

Safety Best Practices (Evidence-Based)

Always use a new syringe for each injection
Rotate injection sites systematically within the same anatomical region
Allow skin antiseptic to dry before injecting to prevent stinging
Store insulin per manufacturer guidelines (avoid freezing or direct sunlight)
Use safety syringes with needle-shielding mechanisms in clinical settings

Disclaimer: This product is intended for research use only. Not for human consumption, therapeutic use, or diagnostic purposes.

Detailed chemical and physical properties.

Needle Gauge

31G (finest)

Needle Length

4mm (recommended)

Barrel Capacity

100units max

Dosing Precision

1unit increment

Insulin — The Delivered Compound

Insulin syringes are designed specifically to deliver exogenous insulin, a polypeptide hormone that regulates blood glucose metabolism.

Property	Details
Chemical Class	Polypeptide hormone
Molecular Weight	~5,808 Da (human insulin monomer)
Structure	51 amino acids; A-chain (21 AA) + B-chain (30 AA) linked by disulfide bonds
Source	Recombinant DNA technology (biosynthetic human insulin); analog modifications
pH of Formulation	7.0–7.8 (neutral formulations)
Concentration	U-100 (100 units/mL) — standard globally; U-200, U-300, U-500 for concentrated formulations
Preservatives	Metacresol, phenol, or parabens (depending on formulation)
Onset of Action	Varies by type: 5 min (rapid-acting) to 1–2 hrs (long-acting)
Route of Administration	Subcutaneous (SC); IV in clinical settings

Types of Insulin Compatible with Syringes

Insulin Type	Brand Examples	Onset	Peak	Duration
Rapid-acting	Humalog, NovoLog, Apidra	5–15 min	1–2 hrs	3–5 hrs
Short-acting (Regular)	Humulin R, Novolin R	30–60 min	2–4 hrs	6–8 hrs
Intermediate-acting	Humulin N (NPH)	1–2 hrs	4–12 hrs	12–18 hrs
Long-acting	Lantus, Levemir, Tresiba	1–2 hrs	Peakless	20–42 hrs
Pre-mixed	Humulin 70/30, NovoMix	Variable	Biphasic	Variable

⚠️ Important: Always match the syringe unit scale (U-100 vs U-500) to the insulin concentration being used. Mismatch can result in dangerous dosing errors.

Common questions about Tirzepatide.

Peer-reviewed publications and reference materials.

American Diabetes Association (ADA)

American Diabetes Association (ADA). Standards of Medical Care in Diabetes. Diabetes Care. 2024. diabetes.org

Frid AH, et al.

Frid AH, et al. “New Insulin Delivery Recommendations.” Mayo Clinic Proceedings. 2016;91(9):1231–1255. DOI: 10.1016/j.mayocp.2016.06.010

Forum for Injection Technique (FIT).

Forum for Injection Technique (FIT). The UK Injection and Infusion Technique Recommendations, 4th Edition. 2016. fit4diabetes.com

This content is intended for educational and informational purposes only. Always consult a licensed healthcare professional or certified diabetes educator before making any changes to your insulin therapy or injection technique.

Related Products

Our products are strictly intended for laboratory research use only. Not for human or animal consumption. By purchasing, you confirm that you are a licensed researcher or purchasing for research purposes.